Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 436

1.

Efficacy of chemopreventive agents in mouse mammary gland organ culture (MMOC) model: a comprehensive review.

Mehta RG, Naithani R, Huma L, Hawthorne M, Moriarty RM, McCormick DL, Steele VE, Kopelovich L.

Curr Med Chem. 2008;15(27):2785-825. Review.

PMID:
18991637
2.

Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals.

Steele VE, Sharma S, Mehta R, Elmore E, Redpath L, Rudd C, Bagheri D, Sigman CC, Kelloff GJ.

J Cell Biochem Suppl. 1996;26:29-53.

PMID:
9154167
3.

25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.

Peng X, Hawthorne M, Vaishnav A, St-Arnaud R, Mehta RG.

Breast Cancer Res Treat. 2009 Jan;113(1):31-41. doi: 10.1007/s10549-008-9900-0. Epub 2008 Jan 20.

4.

Experimental basis for the prevention of breast cancer.

Mehta RG.

Eur J Cancer. 2000 Jun;36(10):1275-82. Review.

PMID:
10882866
5.

Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid.

Udeani GO, Gerhauser C, Thomas CF, Moon RC, Kosmeder JW, Kinghorn AD, Moriarty RM, Pezzuto JM.

Cancer Res. 1997 Aug 15;57(16):3424-8.

6.

Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.

Mehta RG, Liu J, Constantinou A, Thomas CF, Hawthorne M, You M, Gerhüser C, Pezzuto JM, Moon RC, Moriarty RM.

Carcinogenesis. 1995 Feb;16(2):399-404.

PMID:
7859373
7.

A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity.

Shamon LA, Chen C, Mehta RG, Steele V, Moon RC, Pezzuto JM.

Anticancer Res. 1994 Sep-Oct;14(5A):1775-8.

PMID:
7847810
8.

Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.

Mehta RG, Hussain EA, Mehta RR, Das Gupta TK.

Mutat Res. 2003 Feb-Mar;523-524:253-64.

PMID:
12628523
9.
11.

Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).

Mehta R, Hawthorne M, Uselding L, Albinescu D, Moriarty R, Christov K, Mehta R.

J Natl Cancer Inst. 2000 Nov 15;92(22):1836-40.

12.

Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.

Telang NT, Kurihara H, Wong GY, Bradlow HL, Osborne MP.

Anticancer Res. 1991 May-Jun;11(3):1021-7.

PMID:
1909512
13.

Development of breast cancer chemopreventive drugs.

Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Doody LA, Greenwald P.

J Cell Biochem Suppl. 1993;17G:2-13. Review.

PMID:
8007699
14.

Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.

Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ, Lubet RL.

Anticancer Res. 1995 May-Jun;15(3):709-16.

PMID:
7645947
16.
17.

Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer.

Bishayee A, Mandal A, Thoppil RJ, Darvesh AS, Bhatia D.

Int J Cancer. 2013 Sep 1;133(5):1054-63. doi: 10.1002/ijc.28108. Epub 2013 Mar 29.

18.

Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.

Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, et al.

J Cell Biochem Suppl. 1994;20:32-54. Review.

PMID:
7616752
19.

Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture.

Dickens MS, Custer RP, Sorof S.

Proc Natl Acad Sci U S A. 1979 Nov;76(11):5891-5.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk